Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-09

FDA Approved: TEMAZEPAM — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Temazepam from Actavis Pharma, Inc., making a generic Temazepam product eligible for marketing. Temazepam is use…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temazepam (Temazepam)

Snippet

SUPPL AP for TEMAZEPAM (TEMAZEPAM)